Top

Published in:

01-10-2013 | Original Research

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Authors: Julia Fehniger, Feng Lin, Mary S. Beattie, Galen Joseph, Celia Kaplan

Published in: Journal of Genetic Counseling | Issue 5/2013

Abstract

Previous studies examining communication of BRCA1/2 results with relatives and family uptake of BRCA1/2 testing have sampled from predominantly white, high SES cohorts ascertained solely from tertiary care centers. No studies have focused on family communication and testing among relatives of diverse BRCA1/2 carriers. We conducted structured interviews with 73 BRCA1/2 carriers identified at a public hospital and a tertiary cancer center. We asked participants if each first- and second-degree relative was aware of their BRCA1/2 results and whether or not each relative had tested. Generalized estimating equations identified rates and predictors of family communication and testing. Participants disclosed their test results to 73 % of 606 eligible relatives and 31 % of 514 eligible relatives tested. Communication and testing rates were similar for relatives of participants from the public hospital and the tertiary cancer center. Hospital site was not a significant predictor of either result disclosure or relative uptake of testing. African American and Asian/Pacific Islander participants were significantly less likely to disclose their results to their relatives; relatives of African American participants were significantly less likely to test. Addressing these disparities will require further research into the best ways to facilitate family communication and counsel at-risk relatives of racially and socioeconomically diverse BRCA1/2 mutation carriers.

Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., & Schwartz, S. (2003). Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. American Journal of Medical Genetics, 117A, 154–160.PubMed

Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Journal of the American Medical Association, 293(14), 1729–1736.PubMedCrossRef

Barlow-Stewart, K., Yeo, S. S., Meiser, B., et al. (2006). Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24–31.PubMedCrossRef

Berliner, J. L., & Fay, A. M. (2007). Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 16(3), 241–260.PubMedCrossRef

Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93(4), 257–263.PubMedCrossRef

Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2 positive families: initiator role of index cases. Genetic Testing, 7(3), 225–233.PubMedCrossRef

Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. Journal of the American Medical Association, 277(12), 997–1003.PubMedCrossRef

Cheung, E. L., Olson, A. D., Yu, T. M., Han, P. Z., & Beattie, M. S. (2010). Communication of BRCA1/2 results and family testing in 1,103 high-risk women. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2211–2219.CrossRef

Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics, 116A, 11–19.PubMedCrossRef

De Leon Matsuda, M. L., Liede, A., Kwan, E., Mapua, C. A., Cutiongco, E. M., Tan, A., Borg, A., & Narod, S. A. (2002). BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. International Journal of Cancer, 98(4), 596–603.CrossRef

Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., & Isaacs, C. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association, 304(9), 967–975.PubMedCrossRef

Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–92.PubMedCrossRef

Haffty, B. G., Choi, D. H., Goyal, S., Silber, A., Ranieri, K., Matloff, E., et al. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology, 20(10), 1653–1659.PubMedCrossRef

Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) — a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.PubMedCrossRef

Harvey, S. L., Milne, R. L., McLachlan, S. A., Friedlander, M. L., Birch, K. E., & Weideman, P. (2011). Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Research and Treatment, 130(3), 1057–1061.PubMedCrossRef

Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2000). All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107(2), 143–150.CrossRef

Hughes, C., Fasaye, G. A., LaSalle, V. H., & Finch, C. (2003). Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Education and Counseling, 51(2), 107–114.PubMedCrossRef

Kardashian, A., Fehniger, J., Creasman, J., Cheung, E., & Beattie, M. S. (2012). Pilot study of the Sharing Risk Information Tool (ShaRIT) for families with hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, 10, 4.PubMedCrossRef

Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D., et al. (2005). Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Journal of the National Cancer Institute, 97(18), 1382–1384.PubMedCrossRef

Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., Kingham, K. E., et al. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. Journal of Clinical Oncology, 26(29), 4752–4758.PubMedCrossRef

Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., et al. (2011). Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the breast cancer family registry. Journal of Clinical Oncology, 29(34), 4505–4509.PubMedCrossRef

Landsbergen, K., Verhaak, C., Kraaimaat, F., & Hoogerbrugge, N. (2005). Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Familial Cancer, 4(2), 115–119.PubMedCrossRef

Lee, R., Beattie, M., Crawford, B., Mak, J., Stewart, N., Komaromy, M., et al. (2005). Recruitment, genetic counseling, and BRCA1/2 testing for underserved women at a public hospital. Genetic Testing, 9(4), 306–312.PubMedCrossRef

Lerman, C., Hughes, C., Benkendorf, J. L., Biesecker, B., Kerner, J., Willison, J., et al. (1999). Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 361–367.

Lu, K., Kauff, N., Powell, C. B., Chen, L. M., Cass, I., Lancaster, J., et al. (2009). American college of obstetricians and gynecologists practice bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology, 113(4), 957–966.

MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger, J. N., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9(5), 275–282.PubMedCrossRef

McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genetics in Medicine, 6(6), 503–509.PubMedCrossRef

Narod, S. (2009). Screening for BRCA1/2 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective. Salud Pública de México, 51(Suppl 2), S191–S196.PubMedCrossRef

Nathanson, K. L., & Domchek, S. M. (2011). Therapeutic approaches for women predisposed to breast cancer. Annual Review of Medicine, 62, 295–306.PubMedCrossRef

National Comprehensive Cancer Network (2011) Genetic/familial high-risk assessment: breast and ovarian, version 1. Practice guidelines. Available at: http://www.nccn.org. Accessed 23 April 2012.

Offit, K., Groeger, T., Turner, S., Wadsworth, E. A., & Weiser, M. A. (2004). The “duty to warn” a patient’s family members about hereditary disease risks. Journal of the American Medical Association, 292(12), 1469–1473.PubMedCrossRef

Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.PubMedCrossRef

Plon, S. E., Cooper, H. P., Parks, B., Dar, S., Kelly, P. A., Weinberg, A. D., et al. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148–154.PubMedCrossRef

Ratnayake, P., Wakefield, C. E., Meiser, B., Suthers, G., Price, M. A., Duffy, J., et al. (2011). An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Familial Cancer, 10(1), 97–105.PubMedCrossRef

Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta-analysis of risk-reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. Journal of the National Cancer Institute, 101(2), 80–87.PubMedCrossRef

Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.PubMedCrossRef

Sermijn, E., Goelen, G., Teugels, E., Kaufman, L., Vonduelle, M., Neyns, B., et al. (2004). The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. Journal of Medical Genetics, 41(3), e23.PubMedCrossRef

Susswein, L. R., Skrzynia, C., Lange, L. A., Booker, J. K., Graham, M. L., & Evans, J. P. (2008). Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. Journal of Clinical Oncology, 26(1), 32–36.PubMedCrossRef

Thompson, H. B., Jandorf, L., & Redd, W. (2003). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina, and Caucasian women. Patient Education and Counseling, 51(3), 217–227.PubMedCrossRef

U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA1/2 mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine, 143(5), 355–361.CrossRef

Vos, J., Menko, F., Jansen, A. M., van Asperen, C. J., Stiggelbout, A. M., & Tibben, A. (2011). A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Familial Cancer, 10(1), 87–96.PubMedCrossRef

Wagner-Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., & Daly, M. B. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 119C, 11–18.PubMedCrossRef

Yoon, S. Y., Thong, M. K., Taib, N. A., Yip, C. H., & Teo, S. H. (2011). Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Familial Cancer, 10(2), 199–205.PubMedCrossRef

Title: Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers
Authors: Julia Fehniger
Feng Lin
Mary S. Beattie
Galen Joseph
Celia Kaplan
Publication date: 01-10-2013
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 5/2013
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-013-9592-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Exploring Culture-Specific Differences in Beliefs about Causes, Kinship and the Heritability of Major Depressive Disorder: The Views of Anglo-Celtic and Chinese-Australians

More than 10 Years After the First ‘Savior Siblings’: Parental Experiences Surrounding Preimplantation Genetic Diagnosis

Fabry Disease Practice Guidelines: Recommendations of the National Society of Genetic Counselors

Stress and Well-Being Among Parents of Children with Potocki-Lupski Syndrome

Effect of Direct-to-Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential Consumers

Preimplantation Genetic Diagnosis: Understanding What Parents Plan to Tell Their Children About Their Conception